
    
      This study is a prospective, observational, single-center study. Ethical approval was
      obtained from the Institutional Review Board.

      This study will be completed with patients with Vitamin D deficiency. An intravenous cannula
      will be inserted into the antecubital vein. Blood samples will be obtained before and after
      treatment.

      Serum will be collected and will be centrifuged for 15 minutes at 1000Xg within 30 minutes of
      collection. Aliquots of serum will be added to eppendorf tubes and stored at -20Â°C.

      Serum sclerostin levels will be measured using a Human Sclerostin ELISA kit (Cusabio, Catalog
      No: CSB-E13146h, Newark, DE, USA). All assays will be performed according to the
      manufacturer's instructions. The minimum detectable concentration of human sclerostin is
      typically <0.012 ng/ml. Intra-assay precision is less than 8%.
    
  